PD-L1 Blockade Improves Survival in Experimental Sepsis by Inhibiting Lymphocyte Apoptosis and Reversing Monocyte Dysfunction

Critical Care - United Kingdom
doi 10.1186/cc9354
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

PD-L1 Inhibitor Improves Survival in TNBC

Cancer Discovery
Oncology
2018English

PD-L1 Blockade Attenuated Sepsis-Induced Liver Injury in a Mouse Cecal Ligation and Puncture Model

Mediators of Inflammation
ImmunologyCell Biology
2013English

Oncolytic Virus and PD-1/PD-L1 Blockade Combination Therapy

Oncolytic Virotherapy
2018English

FC-99 Ameliorates Sepsis-Induced Liver Dysfunction by Modulating Monocyte/Macrophage Differentiation via Let-7arelated Monocytes Apoptosis

Oncotarget
Oncology
2018English

MA06.03 PD-1 and Id-1 Combined Blockade Impacts Tumor Growth and Survival Through PD-L1 Expression and Tumor Infiltration by Immune-Related Cells

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer

Breast Care
SurgeryOncology
2016English

PAK4 Inhibition Improves PD-1 Blockade Immunotherapy

Nature Cancer
2019English

Pembro Ups Survival in PD-L1–positive HNSCC

Cancer Discovery
Oncology
2018English

Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 Expression

Molecular Cell
Cell BiologyMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy